Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

ESHRE 40th Annual Meeting

Amsterdam, The Netherlands
7-10 July 2024

#ESHRE2024

Join the platform here >

Thank you for participating in our 40th Annual Meeting!

We would like to thank you for making this yet another unforgettable edition of our Annual Meeting and hope you have found it fruitful, informative and enjoyable.

Missed a session? You can still watch it on-demand. The ESHRE 2024 virtual platform remains available to registered participants for 5 months after the meeting has been held.

See you in Paris!



Watch on-demand >

Meet our exhibitors of the Fertility event of the year

Here’s your chance to meet our esteemed exhibitors.

You can find our Exhibitor list here >

Beware of fraudulent websites and e-mails for ESHRE 2024!

We've been alerted about some shady websites posing as us and pretending to offer registration and hotel accomodations for our ESHRE 2024 Annual Meeting.


Read more >

registration

Register now to participate in the world’s greatest event in reproductive science and medicine!
ESHRE members enjoy strongly reduced registration fees.

REGISTER HERE

News

News image
  • FOCUS ON REPRODUCTION

CRISPR – past, present and future

09 July 2024

The origins, benefits and challenges of the CRISPR gene editing tool were outlined in a keynote presentation at ESHRE’s 2024 annual meeting in Amsterdam.

News image
  • press release

Socioeconomic status significantly affects fertility treatment outcomes, new study shows

09 July 2024

Novel research reveals significant social disparities in achieving live births following assisted reproductive technology (ART) treatment.

News image
  • PRESS RELEASE

Novel treatment improves embryo implantation and live birth rates in infertile women undergoing IVF and ICSI

08 July 2024

New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug in increasing embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

News image
  • PRESS RELEASE

Air pollution linked to a decrease in IVF birth rate success, new study shows

08 July 2024

Pioneering study has revealed that exposure to fine particulate matter (PM) prior to the retrieval of oocytes (eggs) during in vitro fertilisation (IVF) can reduce the odds of achieving a live birth by almost 40%.